AI BriefingImpact Program Announcement
Key point
ElevenLabs is providing voice cloning and TTS technology for free to help ALS and MND patients communicate.
Details
ElevenLabs is launching the Impact Program in partnership with Bridging Voice and The Scott-Morgan Foundation. This program aims to remove communication barriers faced by patients with amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND).
As the disease progresses, up to 95% of patients lose their ability to speak. ElevenLabs will provide these patients with its Voice Cloning and Text-to-Speech technology for free, enabling them to communicate in their own voice.
The program proceeds through the following steps:
- Apply for a free voice cloning license through the partner site
- Create a digital voice clone using voice recording data
- Use the voice on the ElevenLabs platform and various assistive technology devices
Through this collaboration, patients will gain a technological foundation to maintain their identity and stay connected with family and society.
This summary was generated automatically by AI. Check the original for the author's claims and context. Copyright belongs to the original author.
Our guide explains how the AI works. Report summary errors, attribution issues, or removal requests via Contact.
Related
Halo NeuroAI Releases Sopro V2 Turbo, a 120M-Parameter Open-Source Voice Cloning TTS with Native European Portuguese Support
Open-source 'VoiceStudio' released with support for local voice cloning, dubbing, and transcription